Literature DB >> 29132248

Gene delivery system of pDNA using the blood glycoprotein fetuin.

Yukinobu Kodama1,2, Hiroki Hanamura2, Takahiro Muro1, Hiroo Nakagawa1, Tomoaki Kurosaki1, Tadahiro Nakamura1, Takashi Kitahara1, Shigeru Kawakami3, Mikiro Nakashima2, Hitoshi Sasaki1.   

Abstract

Fetuin is a biocompatible plasma protein and strongly enhances phagocytosis of bacteria, DNA and apoptotic cells by peripheral blood cells such as monocytes, macrophages and dendritic cells. We developed a novel gene delivery system: ternary complexes constructed with pDNA, polyethylenimine (PEI) and fetuin. Without covalent binding, fetuin was able to coat pDNA-PEI complexes, and stable anionic nanoparticles formed at a weight ratio greater than 30. Optimised pDNA-PEI-fetuin complexes significantly decreased the cytotoxicity of pDNA-PEI complexes in the melanoma cell line B16F10. Furthermore, the pDNA-PEI-fetuin complexes had higher transgene efficiency compared to that of commercial lipofectin previously reported in B16F10 cells despite an anionic surface. The pDNA-PEI-fetuin complexes did not agglutinate with erythrocytes. The pDNA-PEI-fetuin complexes had high gene expression in the spleen after intravenous administration in mice. Thus, the pDNA-PEI-fetuin complexes were a useful in vivo gene delivery system with tropism for the spleen.

Entities:  

Keywords:  Fetuin; gene delivery; plasmid DNA; ternary complex

Mesh:

Substances:

Year:  2017        PMID: 29132248     DOI: 10.1080/1061186X.2017.1405425

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  1 in total

1.  Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice.

Authors:  Yukinobu Kodama; Ayako Tokunaga; Junya Hashizume; Hiroo Nakagawa; Hitomi Harasawa; Tomoaki Kurosaki; Tadahiro Nakamura; Koyo Nishida; Mikiro Nakashima; Mitsuru Hashida; Shigeru Kawakami; Hitoshi Sasaki
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.